3YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| 1-(2,3-Dihydro-6-iodo-7-methyl-1H-pyrido[2,3-b][1,4]oxazin-1-yl)-2,2-dimethyl-1-propanone | 1-（2,3-二氢-6-碘-7-甲基-1H-吡啶[2,3-b][1,4]恶嗪-1-基）-2,2-二甲基-1-丙酮 | 1261365-43-8 |
| Terazosin Impurity 30 | 特拉唑嗪杂质30 | 1260939-66-9 |
| Indacaterol Impurity 85 | 茚达特罗杂质85 | 1261219-83-3 |
| Oxcarbazepine-d8 | 奥卡西平-d8 | 1261396-65-9 |
| Apixaban-13C-d3 | 阿哌沙班-13C-d3 | 1261393-15-0 |
| Axitinib-13C-d3 | 阿昔替尼-13C-d3型 | 1261432-00-1 |
| Dapoxetine Impurity 91 | 达泊西汀杂质91 | 126113-24-4 |
| Phenylephrine Impurity 55 | 苯肾上腺素杂质55 | 1261476-32-7 |
| Ritonavir Impurity 45 | 利托那韦杂质45 | 126147-70-4 |
| Phenylephrine Impurity 54 | 苯肾上腺素杂质54 | 1261439-63-7 |
| Nafamostat Impurity 9 | 萘莫司他杂质9 | 1261626-91-8 |
| Phenylephrine Impurity 53 | 苯肾上腺素杂质53 | 1261645-14-0 |
| Lactulose Impurity 26 | 乳果糖杂质26 | 13007-32-4 |
| Valproic Acid Impurity 9 | 丙戊酸杂质9 | 130000-32-7 |
| Vortioxetine Impurity H | 沃替西汀杂质H | 1293489-69-6 |
| Fmoc-Pro-Pro-OH | N-芴甲氧羰基-脯氨酰-脯氨酸 | 129223-22-9 |
| Risperidone Impurity 42 | 利培酮杂质42 | 130049-87-5 |
| Nebivolol Impurity 6 | 奈必洛尔杂质6 | 129101-34-4 |
| Orlistat Impurity 55 | 奥利司他杂质55 | 130193-41-8 |
| Glycopyrronium Bromide Impurity 14 | 格隆溴铵杂质14 | 129784-11-8 |
| Calcipotriol Impurity 57 | 钙泊三醇杂质57 | 129831-99-8 |
| Ponatinib RC 7 | 普纳替尼 RC 7 | 1300690-48-5 |
| Vortioxetine Impurity G | 沃替西汀杂质G | 1293489-71-0 |
| Levofloxacin Impurity 54 | 左氧氟沙星杂质54 | 129815-82-3 |
| Lafutidine Impurity 15 | 拉呋替丁杂质15 | 129622-98-6 |
| Demeclocycline EP Impurity C;Chlortetracycline EP Impurity C | 去甲金霉素EP杂质C；金霉素EP杂质C | 129044-45-7 |
| Ganirelix Impurity 6 | 加尼瑞克杂质6 | 129225-22-5 |
| Fluorescent Brightener ER-II | 荧光增白剂ER-II | 13001-38-2 |
| Camptothecin Impurity 21 | 喜树碱杂质21 | 130144-34-2 |
| Azvudine Impurity 5 | 阿兹夫定杂质5 | 128496-10-6 |
| Lifitegrast Impurity 59 | 立他司特杂质59 | 1289646-78-1 |
| Dapagliflozin Impurity 169 | 达格列净杂质169 | 1282849-48-2 |
| Dotinurad Impurity 11 | 多蒂纳德杂质11 | 1285573-42-3 |
| Lifitegrast Impurity 57 | 立他司特杂质57 | 1289646-76-9 |
| Isavuconazole Impurity 147 | 艾沙康唑杂质147 | 1286730-05-9 |
| Dapagliflozin Impurity 166 | 达格列净杂质166 | 1284798-26-0 |
| PyBOP | 1H-苯并三唑-1-基氧三吡咯烷基六氟磷酸盐 | 128625-52-5 |
| Eberconazole | 依柏康唑 | 128326-82-9 |
| Pyrene | 芘 | 129-00-0 |
| Tryptophan EP Impurity B (R-Isomer) | 色氨酸EP杂质B（R-异构体） | 128303-30-0 |
| Voriconazole Impurity 33 | 伏立康唑杂质33 | 1289559-76-7 |
| Capecitabine Impurity 35 | 卡培他滨杂质35 | 128963-10-0 |
| Lifitegrast Impurity 43 | 立他司特杂质43 | 1289646-72-5 |
| Cabotegravir Impurity 10 | 卡博特韦杂质10 | 1284487-51-9 |
| Glutathione Impurity 20 | 谷胱甘肽杂质20 | 128960-77-0 |
| Rimegepant | 瑞美吉泮 | 1289023-67-1 |
| Fluorescent Brightener 199 (ER-I) | 荧光增白剂199（ER-I） | 13001-39-3 |
| Orlistat Impurity 51 | 奥利司他杂质51 | 130193-40-7 |
| Ketorolac Impurity 57 | 酮咯酸杂质57 | 130190-60-2 |
| Rapamycin Impurity 13 | 雷帕霉素杂质13 | 1290606-20-0 |
| Darolutamide Impurity 1 | 达罗他胺杂质1 | 1297537-37-1 |
| ((2R,3S,5R)-3-((4-chlorobenzoyl)oxy)-5-(2,4-dioxo-5-(trifluoromethyl)-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl 4-chlorobenzoate | （（2R，3S，5R）-3-（（4-氯苯甲酰基）氧基）-5-（2,4-二氧基-5-（三氟甲基）-3,4-二氢嘧啶-1（2H）-基）四氢呋喃-2-基）甲基-4-氯苯甲酸酯 | 129664-47-7 |
| Vortioxetine Impurity F | 沃替西汀杂质F | 1293489-74-3 |
| Sorafenib Impurity 17 | 索拉非尼杂质17 | 1290546-48-3 |
| (E)-3-(2-formylphenyl)acrylic acid | （E）-3-（2-甲酰基苯基）丙烯酸 | 130036-17-8 |
| Lenvatinib Impurity 170 | 乐伐替尼杂质170 | 126644-71-1 |
| Selexipag-d6 | 赛乐西帕-d6 | 1265295-92-8 |
| Opicapone Impurity 19 | 阿片哌酮杂质19 | 1268126-55-1 |
| Cariprazine Impurity 15 | 卡利拉嗪杂质15 | 1267061-38-0 |
| Acoziborole | 4-氟-N-(1-羟基-3,3-二甲基-1,3-二氢苯并[C][1,2]噁硼戊环-6-基)-2-(三氟甲基)苯甲酰胺 | 1266084-51-8 |
| Ioversol Impurity 11 | 碘佛醇杂质11 | 126736-35-4 |
| (E)-5-(3,7-dimethyl-5-oxoocta-2,6-dien-1-yl)-4-hydroxy-6-methoxyisobenzofuran-1(3H)-one | （E）-5-（3,7-二甲基-5-氧代辛烷-2,6-二烯-1-基）-4-羟基-6-甲氧基异苯并呋喃-1（3H）-酮 | 126654-52-2 |
| Solasodine | 澳洲茄胺 | 126-17-0 |
| Olaparib Impurity 67 | 奥拉帕尼杂质67 | 1261759-41-4 |
| Venetoclax Impurity 14 | 维奈妥拉杂质14 | 1261761-91-4 |
| Phenylephrine Impurity 56 | 苯肾上腺素杂质56 | 1261792-69-1 |
| Lubiprostone Impurity 18 | 鲁比前列酮杂质18 | 1263283-38-0 |
| Gemcitabine Impurity 26 | 吉西他滨杂质26 | 1268237-46-2 |
| Pirfenidone Impurity 20 | 吡非尼酮杂质20 | 126209-21-0 |
| Metabolite-d6 | 代谢物-d6 | 1265295-56-4 |
| Quinidine-d3 | 奎尼丁-d3 | 1267657-68-0 |
| Dimedone | 二甲基酮 | 126-81-8 |
| Rifaximin-d6 | 利福昔明-d6 | 1262992-43-7 |
| Estriol Impurity 15 | 雌三醇杂质15 | 126647-89-0 |
| Nabumetone EP Impurity D | 萘丁美酮EP杂质D | 127053-22-9 |
| Tofacitinib Impurity 60 | 托法替尼杂质60 | 1269823-96-2 |
| GCLE Impurity 1 | GCLE杂质1 | 1269661-23-5 |
| 2-(2-fluorophenoxy)phenol | 2-（2-氟苯氧基）苯酚 | 1268486-26-5 |
| Crizotinib Impurity 16 | 克唑替尼杂质16 | 1269429-29-9 |
| Pazufloxacin Impurity 9 | 帕珠沙星杂质9 | 127046-18-8 |
| Lifitegrast Impurity 49 | 立他司特杂质49 | 1270324-69-0 |
| 5β-Dihydroprogesterone | 5β-二氢孕酮 | 128-23-4 |
| Tenofovir Impurity 233 | 替诺福韦杂质233 | 1280130-08-6 |
| Losartan Potassium Impurity 5 | 氯沙坦钾杂质5 | 128208-24-2 |
| Betahistine Impurity 9 | 倍他司汀杂质9 | 128225-22-9 |
| 2,4-dimethyl-7H-pyrrolo[2,3-d]pyrimidine | 2,4-二甲基-7H-吡咯并[2,3-d]嘧啶 | 128266-84-2 |
| Rosuvastatin D3 | 瑞舒伐他汀D3 | 1279031-70-7 |
| Suvorexant Impurity 14 | 苏沃雷生杂质14 | 1276666-15-9 |
| Quinoxyfen | 苯肾上腺素-D3 | 1276732-88-7 |
| Landiolol Impurity 35 | 兰地洛尔杂质35 | 128009-85-8 |
| Metoclopramide Impurity 23 | 甲氧氯普胺杂质23 | 1279870-17-5 |
| Benazepril-d5 | 贝那普利-d5 | 1279200-03-1 |
| Beta-Pinene | beta-蒎烯 | 127-91-3 |
| Benazeprilat-d5 (Benazepril EP Impurity C-d5) | 苯那普利拉-d5（苯那普利EP杂质C-d5） | 1279033-05-4 |
| Flucloxacillin sodium EP Impurity B | 氟氯西林钠EP杂质B | 1276016-89-7 |
| Topiramate D12 | 托吡酯D12 | 1279037-95-4 |
| Sitafloxacin Impurity 62 | 西他沙星杂质62 | 127199-27-3 |
| Doxercalciferol Impurity 2 | 度骨化醇杂质2 | 127516-23-8 |
| Vitamin K1 Impurity 139 | 维生素K1杂质139 | 127184-28-5 |
| Sitafloxacin RRS isomer | 西他沙星RRS异构体 | 127254-10-8 |
联系方式
